ING Groep NV Cuts Stock Position in Amedisys, Inc. (NASDAQ:AMED)

ING Groep NV lowered its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 72.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 62,000 shares of the health services provider's stock after selling 160,300 shares during the period. ING Groep NV owned approximately 0.19% of Amedisys worth $5,984,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of AMED. SG Americas Securities LLC increased its holdings in Amedisys by 41.6% during the 2nd quarter. SG Americas Securities LLC now owns 38,315 shares of the health services provider's stock valued at $3,517,000 after purchasing an additional 11,264 shares during the period. BNP Paribas Financial Markets boosted its position in Amedisys by 111.7% during the 1st quarter. BNP Paribas Financial Markets now owns 12,050 shares of the health services provider's stock valued at $1,111,000 after acquiring an additional 6,358 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Amedisys by 4.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider's stock valued at $47,202,000 after acquiring an additional 19,660 shares in the last quarter. California State Teachers Retirement System boosted its position in Amedisys by 65.8% during the 1st quarter. California State Teachers Retirement System now owns 54,592 shares of the health services provider's stock valued at $5,031,000 after acquiring an additional 21,671 shares in the last quarter. Finally, Cetera Advisors LLC bought a new stake in shares of Amedisys in the 1st quarter worth approximately $1,556,000. Hedge funds and other institutional investors own 94.36% of the company's stock.

Amedisys Stock Performance

AMED traded down $0.24 during mid-day trading on Friday, reaching $90.05. 501,387 shares of the company traded hands, compared to its average volume of 357,927. The stock has a market capitalization of $2.95 billion, a P/E ratio of 35.73, a P/E/G ratio of 1.86 and a beta of 0.78. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The company's fifty day moving average price is $96.04 and its 200-day moving average price is $95.80. Amedisys, Inc. has a 52-week low of $89.55 and a 52-week high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). The company had revenue of $587.67 million during the quarter, compared to analysts' expectations of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The company's revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the company earned $0.98 earnings per share. On average, sell-side analysts expect that Amedisys, Inc. will post 4.66 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Cantor Fitzgerald reissued a "neutral" rating and issued a $101.00 price target on shares of Amedisys in a research report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft cut Amedisys from a "buy" rating to a "hold" rating and set a $101.00 price target on the stock. in a research report on Monday, July 29th. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Amedisys presently has a consensus rating of "Hold" and an average price target of $100.67.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.